Abstract
Several lines of evidence suggest a viral infection as the initiating event for the development of myocarditis (MC). Especially enteroviruses like coxsackie B3 virus have been shown to induce MC in humans and strains of MC-prone mice after an infection. The further course of the disease is, however, determined not only by the viral infection but also by the host’s immune system. Both the humoral and the cellular immune system can modify the extent of the damage caused by the disease. The humoral immune system mounts an anti-viral immune response immediately after the infection; however, during the course of the disease, autoantibodies against a variety of different autoantigens emerge. The epitopes recognized by the anti-viral antibodies and those of several autoantibodies have been identified using synthetic peptides. The human disease could be transferred into SCID mice using peripheral blood leukocytes of patients, suggesting a pathophysiological significance of the autoimmune reaction. However, the significance of the humoral immune responses needs to be tested in randomized, prospective studies using immunoadsorption of autoantibodies in patients with inflammatory cardiomyopathy.
Similar content being viewed by others
References
Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530
Bowles NE, Richardson PJ, Olsen EGJ, Archard LC (1986) Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet I:1120–1123
De Scheerder IK, De Buyzere M, Delanghe J, Maas A, Clement DL, Wieme R (1991) Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease. Eur Heart J 12 (Suppl D):88–94
Duchusal MA, McConahey PJ, Robinson CA, Dixon FJ (1990) Transfer of human lupus erythmatodes in severe combined immunodeficient (SCID) mice. J Exp Med 172:985–988
Felix SB, Staudt A, Doerffel WV (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590–1598
Gnann JW, Schwimmbeck PL, Nelson JA, Truax BB, Oldstone MBA (1987) Diagnosis of AIDS using a 12 amino acid peptide representing an immunodominant epitope of human immunodeficiency virus. J Infect Dis 156:261–267
Haarmann CM, Schwimmbeck PL, Mertens T, Schultheiss HP, Strauer B (1994) Identification of serotype-specific and nonserotype-specific B-cell epitopes of Coxsackie B viruses using synthetic peptides. Virology 200:381–389
Helin M, Savola J, Lapinleimu K (1968) Cardiac manifestations during a coxsackie B5 epidemic. Br Med J 3:97–99
Huber SA, Lodge PA (1984) Coxsackie B3 myocarditis in BALB/c mice: evidence for autoimmunity to myocyte antigens. Am J Physiol 116:21–27
Huber SA, Polgar J, Moraska A, Cunningham M, Schwimmbeck P, Schultheiss HP (1993) T lymphocyte responses in CVB3-induced murine myocarditis. Scand J Infect Dis 88:67–78
Krams SM, Dorshkind K, Gershwin ME (1989) Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 170:1919–1930
Kuehl U, Daun B, Seeberg B, Schultheiss HP, Strauer BE (1992) Dilated cardiomyopathy—a chronic myocarditis? Herz 17:97–106
Limas CJ, Limas C (1991) Beta-adrenoreceptor antibodies and genetics in dilated cardiomyopathy: an overview and review. Eur Heart J 12 (Suppl D):175–177
Macht L, Kukuma N, Leader K, Sarsero D, Pegg CAS, Phillips DIW, Yates P, McLachlan SM, Elson C, Smith BR (1991) Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol 84:34–42
Mertens T, Pika U, Eggers HJ (1983) Cross antigenicity among enteroviruses as revealed by immunoblot technique. Virology 129:431–442
Mueller J, Wallukat G, Dandel M (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 35: 385–391
Murphy WJ, Bennett M, Anver MR, Baseler M, Longo DL (1992) Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 22:1421–1427
Noutsias M, Seeberg B, Schultheiss HP, Kuhl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammarory cardiomyopathy. Circulation 99:2124–2131
Oldstone MBA, Schwimmbeck P, Dyrberg T, Fujinami R (1986) Mimicry by virus of host molecules: implications for autoimmune disease. In: Cinader B, Miller RG (eds) Progress in immunology, vol 4. Academic Press, San Diego, pp 787–795
Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schulltheiss HP (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895
Phillips RA, Spaner DE (1991) The SCID mouse: mutation in a DNA repair gene creates recipients useful for studies on stem cells, lymphocyte development and graft-versus-host disease. Immunol Rev 124:63–73
Richardson P, McKenna W, Bristow M (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842
Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB (1991) Epstein-Barr virus (EBV) -associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147–158
Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: Biology, function and clinical application. Ann Intern Med 113:619–627
Schultheiss HP, Bolte HD, Schwimmbeck P, Klingenberg M (1983) The antigenic characteristics and the significance of the adenine nucleotide translocator (ANT) as a major autoantigen for antimitochondrial antibodies in myocarditis and congestive cardiomyopathy. J Mol Cell Cardiol 15:85–93
Schulze K, Becker BF, Schultheiss HP (1989) Antibodies to the ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 64:179–192
Schulze K, Becker BF, Schauer R, Schultheiss HP (1990) Antibodies to ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—impair cardiac function. Circulation 81:959–969
Schwimmbeck PL, Schwimmbeck NK, Schultheiss HP, Strauer BE (1993) Mapping of antigenic determinants of the adenine nucleotide translocator and coxsackie B 3 virus with synthetic peptides: use for the diagnosis of viral heart disease. Clin Immunol Immunpathol 68:135–140
Schwimmbeck PL, Badorff C, Schultheiss HP, Strauer BE (1994) Transfer of human myocarditis into severe combined immundeficiency mice. Circ Res 75:156–164
Schwimmbeck PL, Badorff C, Rohn G, Schulze K, Schultheiss HP (1996) The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 54:117–125
Smith SC, Allen PM (1991) Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 147:2141–2147
Tighe H, Silverman GJ, Kozin F, Tucker R, Gulizia R, Peebles C, Lotz M, Rhodes G, Machold K, Mosier DE, Carson DA (1990) Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol 20:1843–1848
Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR (1986) Variations in the susceptibility to coxsackie B3 virus induced myocarditis among different strains of mice. J Immunol 136:1846–1852
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schwimmbeck, P.L., Bigalke, B., Schulze, K. et al. The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies. Med Microbiol Immunol 193, 115–119 (2004). https://doi.org/10.1007/s00430-003-0217-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-003-0217-7